8 results
P
Patients with odontogenic keratocyst (OKC)
I/C
5-Fluorouracil (5-FU) as an adjunct following surgical intervention, Surgical intervention alone
O
Recurrence rate and nerve paraesthesia
P
MAC patients, AC patients
I/C
neoadjuvant treatment regimens comprising chemoradiotherapy (CRT) with fluorouracil (5-FU) or mFOLFOX6, neoadjuvant chemotherapy alone with mFOLFOX6 or mFOLFOXIRI, MAC vs. AC patients
O
pathological complete response (pCR) rate, tumor downstaging rate, 3-year DFS, 3-year locoregional recurrence rate
P
patients with locally advanced rectal cancer (LARC)
I/C
neoadjuvant (chemo) radiotherapy and curative surgery, observation group
O
overall survival (OS), disease-free survival (DFS), toxicity, compliance
P
Orthodontic-surgical treatment patients
I/C
Conventional combined orthodontic-surgical treatment, No treatment or alternative treatments
O
Oral health-related quality of life
P
Nicotinamide, Tryptophan, Dietary supplements
I/C
Chemopreventive agent, Squamous cell carcinoma
O
Keratinocyte cancers
P
emerging adults
I/C
societal developments such as increased fragmentation of social relationships, greater mobility opportunities, and changes in communication due to technological innovations, loneliness levels in emerging adults over time
O
increase in loneliness levels linearly with increasing calendar years
P
HIGH-GRADE SQUAMOUS INTRAEPITHELIAL LESION (HSIL)
I/C
DRUGS, SURGERY, PLACEBO
O
HISTOLOGICAL REGRESSION RATE OF CERVICAL LESIONS
P
patients before and after primary total knee arthroplasty (TKA)
I/C
primary total knee arthroplasty (TKA), preoperative and postoperative sport participation rates
O
improvement of sport activity based on validated activity scores, postoperative improvement of sport activity based on validated activity scores, sport participation rates and the return to sport rates (RTS)